Krsnaa Diagnostics Ltd
Krsnaa Diagnostics Ltd (KRSNAA) last reported results for the quarter ended Jun 2026, with sales of ₹236 crore and net profit of ₹17 crore. Krsnaa Diagnostics Ltd’s board meets on 16 Oct 2026. The stock last traded at ₹553, a market capitalisation of ₹1,794 crore, on a P/E of 18.4. Over the past 52 weeks the stock has ranged between ₹502 and ₹849. Figures are as of 6 Oct 2026 and are not real time.
Krsnaa Diagnostics Ltd share price and key metrics
- Current price
- ₹553
- Market cap
- ₹1,794 cr
- Stock P/E
- 18.4
- Book value
- ₹302
- ROE
- 10.9%
- ROCE
- 12.7%
- Dividend yield
- 0.36%
- 52w high / low
- 849/502
Metrics as of 6 Oct 2026. Not real time.
Track Krsnaa Diagnostics Ltd
Cruxal reads every Krsnaa Diagnostics Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Krsnaa Diagnostics Ltd growth and returns
- 10 Years
- 35%
- 5 Years
- %
- 3 Years
- 17%
- TTM
- 10%
- 10 Years
- 37%
- 5 Years
- %
- 3 Years
- 18%
- TTM
- 22%
- 10 Years
- %
- 5 Years
- -7%
- 3 Years
- -7%
- 1 Year
- -28%
- 10 Years
- %
- 5 Years
- 9%
- 3 Years
- 9%
- Last Year
- 11%
Krsnaa Diagnostics Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹236 cr, up 22.3% from ₹193 cr a year earlier. Net profit was ₹17 cr, down 19.0% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 186 | 175 | 186 | 193 | 206 | 181 | 193 | 236 |
| Expenses | 137 | 129 | 133 | 142 | 147 | 135 | 138 | 178 |
| Operating profit | 49 | 45 | 53 | 51 | 59 | 46 | 55 | 58 |
| OPM % | 27% | 26% | 28% | 27% | 29% | 26% | 28% | 25% |
| Other income | 5 | 9 | 4 | 4 | 4 | 4 | 32 | 7 |
| Interest | 6 | 6 | 7 | 6 | 8 | 8 | 12 | 15 |
| Depreciation | 22 | 23 | 22 | 22 | 24 | 23 | 23 | 28 |
| Profit before tax | 25 | 25 | 29 | 27 | 32 | 20 | 52 | 22 |
| Tax % | 23% | 24% | 28% | 25% | 24% | 23% | 19% | 26% |
| Net profit | 20 | 19 | 21 | 21 | 24 | 15 | 42 | 17 |
| EPS (₹) | 6.07 | 6.01 | 6.40 | 6.33 | 7.38 | 4.70 | 12.86 | 5.10 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Krsnaa Diagnostics Ltd annual results
| ₹ crore | Mar 2016 | Mar 2017 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 39 | 61 | 455 | 487 | 620 | 717 | 773 | 815 |
| Operating profit | 9 | 19 | 132 | 122 | 144 | 190 | 212 | 218 |
| OPM % | 23% | 31% | 29% | 25% | 23% | 27% | 27% | 27% |
| Net profit | -5 | -0 | 68 | 62 | 57 | 78 | 101 | 97 |
| EPS (₹) | -9.53 | -0.14 | 21.78 | 19.78 | 17.60 | 24.04 | 31.27 | 30.04 |
TTM is the trailing twelve months to the most recent quarter.
Krsnaa Diagnostics Ltd balance sheet
| ₹ crore | Mar 2016 | Mar 2017 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity capital | 5 | 5 | 16 | 16 | 16 | 16 | 16 |
| Reserves | 6 | 6 | 669 | 723 | 794 | 867 | 964 |
| Borrowings | 131 | 102 | 41 | 32 | 160 | 204 | 534 |
| Other liabilities | 44 | 80 | 150 | 137 | 201 | 192 | 304 |
| Total liabilities | 186 | 192 | 875 | 908 | 1,170 | 1,278 | 1,819 |
| Fixed assets | 74 | 131 | 386 | 471 | 647 | 670 | 656 |
| CWIP | 20 | 6 | 28 | 25 | 10 | 3 | 208 |
| Investments | 1 | 1 | 0 | 0 | 0 | 32 | 57 |
| Other assets | 91 | 55 | 461 | 412 | 513 | 573 | 897 |
| Total assets | 186 | 192 | 875 | 908 | 1,170 | 1,278 | 1,819 |
As reported by the company. Total assets equal total liabilities by construction.
Krsnaa Diagnostics Ltd cash flow
| ₹ crore | Mar 2016 | Mar 2017 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -23 | 64 | 128 | 76 | 24 | 87 | 143 |
| Cash from investing | -47 | -54 | -241 | -109 | -129 | -100 | -396 |
| Cash from financing | 105 | -41 | 176 | -33 | 84 | 14 | 279 |
| Net cash flow | 36 | -31 | 64 | -66 | -20 | 1 | 26 |
| Free cash flow | -69 | 10 | -3 | -58 | -169 | -24 | -72 |
| CFO / operating profit | -254% | 344% | 103% | 73% | 30% | 56% | 81% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Krsnaa Diagnostics Ltd operating ratios
| Per year | Mar 2016 | Mar 2017 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| ROCE % | — | 7% | — | 12% | 10% | 12% | 13% |
| Debtor days | 79 | 84 | 46 | 55 | 104 | 141 | 140 |
| Inventory days | 21 | 24 | — | — | — | — | — |
| Days payable | 76 | 100 | — | — | — | — | — |
| Cash conversion cycle | 24 | 8 | 46 | 55 | 104 | 141 | 140 |
| Working capital days | -69 | -113 | -23 | 11 | -21 | 21 | 48 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Krsnaa Diagnostics Ltd shareholding pattern
Promoters held 27.11% at Jun 2026, broadly unchanged since Jun 2025. FIIs 4.28% and DIIs 14.51%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 27.17% | 27.24% | 27.24% | 27.11% | 27.11% | 27.11% | 27.11% | 27.11% |
| FIIs | 3.63% | 4.04% | 3.55% | 3.40% | 3.66% | 4.17% | 3.91% | 4.28% |
| DIIs | 15.86% | 14.46% | 14.26% | 14.24% | 14.96% | 13.85% | 13.89% | 14.51% |
| Public | 53.34% | 54.27% | 54.94% | 55.25% | 54.27% | 54.86% | 55.09% | 54.08% |
| No. of shareholders | 53,519 | 52,799 | 53,559 | 54,262 | 52,117 | 52,380 | 53,022 | 53,625 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When does Krsnaa Diagnostics Ltd’s board next meet?
Krsnaa Diagnostics Ltd’s board meets on 16 Oct 2026.
- Board meetingIssue of 16,21,000 warrants on preferential basis
See the full results calendar for every Indian company reporting in the next 30 days.
Krsnaa Diagnostics Ltd corporate filings
- Intimation of In-Principle Approval for Issue of 16,21,000 Convertible Warrants to Promoter GroupCompany Updatelow impact
Cruxal's analysis: Krsnaa Diagnostics Ltd has received in-principle approval from BSE for the issuance of…
Read the full analysis - Krsnaa Diagnostics Receives In-Principle Approval for Warrant IssueCompany Updatelow impact
Cruxal's analysis: Krsnaa Diagnostics Ltd has announced receipt of in-principle approval for the issuance of…
Read the full analysis - Krsnaa Diagnostics Receives In-Principle Approval for Issue of 16,21,000 Warrants Convertible into Equity SharesCompany Updatelow impact
Cruxal's analysis: Krsnaa Diagnostics Ltd has obtained regulatory approval to issue 16,21,000 warrants…
Read the full analysis - Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018Company Updatelow impact
- Krsnaa Diagnostics Limited's AGM Voting Results Confirm Requisite Majorities for All Resolutions, Including Financial Statements, Dividends, and Director ReappointmentsAGM/EGMmedium impact
Cruxal's analysis: Krsnaa Diagnostics Limited has successfully passed all key resolutions at its 16th AGM…
Read the full analysis - Krsnaa Diagnostics Appoints M/s Kirtane & Pandit LLP as Statutory Auditor for 5-Year TermCompany Updatelow impact
Cruxal's analysis: Krsnaa Diagnostics Limited announced the appointment of M/s Kirtane & Pandit LLP as its…
Read the full analysis - Krsnaa Diagnostics Limited conducts successful AGM with high voting turnout; approves final dividend of INR 2 per shareAGM/EGMlow impact
Cruxal's analysis: Krsnaa Diagnostics Limited held its 16th Annual General Meeting on September 28, 2026…
Read the full analysis - Krsnaa Diagnostics Ltd: Routine Regulatory Disclosure under SEBI LODRCompany Updatelow impact
Cruxal's analysis: Krsnaa Diagnostics Ltd has filed a routine disclosure under Regulation 30(6) of the SEBI…
Read the full analysis - Krsnaa Diagnostics Limited concludes 16th AGM; declares final dividend of INR 2.00 per shareAGM/EGMlow impact
Cruxal's analysis: Krsnaa Diagnostics Limited has successfully concluded its 16th Annual General Meeting…
Read the full analysis - Intimation of closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015Insider Trading / SASTlow impact
- Krsnaa Diagnostics shareholders approve preferential issuance of 16.21 lakh convertible warrants to promotersAGM/EGMmedium impact
Cruxal's analysis: Krsnaa Diagnostics Limited has received shareholder approval via postal ballot for the…
Read the full analysis - Krsnaa Diagnostics executes concession agreement for PET-CT diagnostic facilities in PunjabCompany Updatemedium impact
Cruxal's analysis: Krsnaa Diagnostics has formally executed a concession agreement with the relevant…
Read the full analysis - Krsnaa Diagnostics Ltd: Intimation regarding Regulation 36(1)(B) of SEBI Listing RegulationsCompany Updatelow impact
Cruxal's analysis: Krsnaa Diagnostics has issued a routine regulatory filing under Regulation 36(1)(B) of…
Read the full analysis - Krsnaa Diagnostics Ltd files routine disclosure under SEBI Regulation 30Company Updatelow impact
Cruxal's analysis: Krsnaa Diagnostics Ltd has submitted a routine disclosure under Regulation 30 of the SEBI…
Read the full analysis - Krsnaa Diagnostics Ltd announces 16th Annual General MeetingCompany Updatelow impact
Cruxal's analysis: Krsnaa Diagnostics Ltd has published a newspaper notice regarding the convening of its…
Read the full analysis - Krsnaa Diagnostics Ltd files Business Responsibility and Sustainability Report (BRSR) for FY 2025-26Otherslow impact
Cruxal's analysis: Krsnaa Diagnostics Ltd has submitted its Business Responsibility and Sustainability…
Read the full analysis - Krsnaa Diagnostics Ltd releases Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Krsnaa Diagnostics Limited has filed its Annual Report for the financial year 2025-26…
Read the full analysis - Krsnaa Diagnostics Limited Announces 16th Annual General Meeting for FY 2025-26AGM/EGMlow impact
Cruxal's analysis: Krsnaa Diagnostics Limited has issued the notice for its 16th Annual General Meeting…
Read the full analysis - Krsnaa Diagnostics Ltd announces newspaper publication for 16th Annual General MeetingCompany Updatelow impact
Cruxal's analysis: Krsnaa Diagnostics has published the mandatory newspaper notice regarding its 16th Annual…
Read the full analysis - Krsnaa Diagnostics issues corrigendum regarding Postal BallotCompany Updatelow impact
Cruxal's analysis: Krsnaa Diagnostics has published a newspaper notice regarding a corrigendum to its…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.